Professor Olivia Wu

William R Lindsay Chair of Health Economics (Health Economics & Health Technology Assessment)

telephone: 01413303296
email: Olivia.Wu@glasgow.ac.uk

ORCID iD https://orcid.org/0000-0002-0570-6016

Biography

Olivia holds the William R Lindsay Chair of Health Economics and is Director of the HEHTA Research Unit at University of Glasgow, and Visiting Professor at Mahidol University in Thailand. She is also Director of the National Institute for Health Research (NIHR) Complex Reviews Support Unit (CRSU) – a national methods support unit for evidence synthesis.

Olivia has expertise in a broad range of health technology assessment (HTA) methodologies and is interested in adapting and applying HTA methodologies in context. She has a particular interest in evidence synthesis and economic evaluations. Her research spans across a wide range of clinical areas and different types of health technologies (e.g. pharmacological treatments, medical devices and diagnostic tests). Her work has informed clinical guidelines and health policy decisions, both at national and international levels.

In addition to her research, Olivia has been a long-standing member of the NICE Technology Appraisal Committee and advisor to Healthcare Improvement Scotland. She has also been advisor to HTA agencies in Brazil, China, Taiwan and Thailand. Olivia serves as a member of NIHR Systematic Review Programme Advisory Group (since 2015), the NIHR HTA General Board (since 2016) and the Appointment Panel for NIHR Senior Investigator (2018). Previously, she was member:

NIHR Evidence Synthesis Board (2015-2016)
Health Research Board Ireland panels for Capacity Building in Evidence Synthesis (2018) and for Collaboration in Ireland for Clinical Effectiveness Review (2016)
Chief Scientist Office Scotland Health Services and Population Health Research Committee (2010-2015)

More recently, Olivia has been appointed as a member of the Unit of Assessment sub-panel 2 (Public Health, Health Services and Primary Care) for the upcoming Research Excellence Framework 2021.

Research interests

Applied and methodological research in health technology assessment, with focus on the areas of evidence synthesis, risk, prediction modelling and economic evaluation.

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

Number of items: 132.

2022

Wu, T. et al. (2022) The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study Corresponding. Surgery for Obesity and Related Diseases, 18(6), pp. 762-771. (doi: 10.1016/j.soard.2022.02.008) (PMID:35300912)

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818)

Dunlop, E. et al. (2022) What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer. Supportive Care in Cancer, 30(4), pp. 3141-3150. (doi: 10.1007/s00520-021-06724-6) (PMID:34878587) (PMCID:PMC8857102)

McMeekin, N. et al. (2022) Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study. Tobacco Control, (doi: 10.1136/tobaccocontrol-2021-056991) (PMID:35256533) (Early Online Publication)

ten Ham, R. M.T., Frederix, G. W.J., Wu, O. , Goettsch, W., Leufkens, H. G.M., Klungel, O. H. and Hoekman, J. (2022) Key considerations in the health technology assessment of advanced therapy medicinal products in Scotland, The Netherlands, and England. Value in Health, 25(3), pp. 390-399. (doi: 10.1016/j.jval.2021.09.012) (PMID:35227451)

Ciminata, G., Geue, C. , Wu, O. , Deidda, M. , Kreif, N. and Langhorne, P. (2022) Propensity score methods for comparative-effectiveness analysis: a case study of direct oral anticoagulants in the atrial fibrillation population. PLoS ONE, 17(1), e0262293. (doi: 10.1371/journal.pone.0262293) (PMID:35073380) (PMCID:PMC8786176)

Daniels, J. et al. (2022) Uterine artery embolization or myomectomy for women with uterine fibroids: four-year follow-up of a randomised controlled trial. European Journal of Obstetrics and Gynecology and Reproductive Biology: X, 13, 100139. (doi: 10.1016/j.eurox.2021.100139) (PMID:34877531) (PMCID:PMC8633559)

Hsieh, P. H., Geue, C. , Wu, O. , McIntosh, E. and Siebert, S. (2022) How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? RMD Open, 8, e002454. (doi: 10.1136/rmdopen-2022-002454) (PMID:36104116) (PMCID:PMC9476122)

Kamaruzaman, H., Grieve, E. and Wu, O. (2022) Disinvestment in healthcare: a scoping review of systematic reviews. International Journal of Technology Assessment in Health Care, 38(1), e69. (doi: 10.1017/S0266462322000514) (PMID:35853843)

Turongkaravee, S., Praditsitthikorn, N., Ngamprasertchai, T., Jittikoon, J., Mahasirimongkol, S., Sukasem, C., Udomsinprasert, W., Wu, O. and Chaikledkaew, U. (2022) Economic evaluation of multiple-pharmacogenes testing for the prevention of adverse drug reactions in people living with HIV. ClinicoEconomics and Outcomes Research, 14, pp. 447-463. (doi: 10.2147/CEOR.S366906)

Wu, O. , Morris, S., Larsen, T. B., Skjøth, F., Evans, A., Bowrin, K., Wojciechowski, P., Margas, W. and Huelsebeck, M. (2022) Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies. Cardiovascular Therapeutics, 2022, 2756682. (doi: 10.1155/2022/2756682) (PMID:35801133) (PMCID:PMC9203223)

2021

Kanie, T. et al. (2021) Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis (Review). Cochrane Database of Systematic Reviews, 2021(10), CD013650. (doi: 10.1002/14651858.CD013650.pub2)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Wu, O. (2021) Microsimulation model for health economic evaluation of public health policies: an imperfect but useful tool. Circulation, 144(17), pp. 1377-1379. (doi: 10.1161/CIRCULATIONAHA.121.056502)

Alexander, J., Langhorne, P. , Kidd, L. , Wu, O. , McConnachie, A. , van Wijck, F. and Dawson, J. (2021) SaeboGlove therapy for upper limb disability and severe hand impairment after stroke (SUSHI): study protocol for a randomised controlled trial. European Stroke Journal, 6(3), pp. 302-310. (doi: 10.1177/23969873211036586) (PMCID:PMC8564154)

Heggie, R., Boyd, K. and Wu, O. (2021) How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Research Policy and Systems, 19, 118. (doi: 10.1186/s12961-021-00766-2)

Wong, C. K.H., Wu, T., Wong, S. K.H., Law, B. T.T., Grieve, E. , Ng, E. K.W., Wu, O. and Lam, C. L.K. (2021) Effects of bariatric surgery on kidney diseases, cardiovascular diseases, mortality and severe hypoglycaemia among patients with Type 2 diabetes mellitus. Nephrology Dialysis Transplantation, 36(8), pp. 1440-1451. (doi: 10.1093/ndt/gfaa075) (PMID:32591819)

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Wu, T., Wong, S.K.H., Law, B.T.T., Grieve, E. , Wu, O. , Tong, D.K.H., Leung, D.K.W., Ng, E.K.W., Lam, C.L.K. and Wong, C.K.H. (2021) Bariatric surgery is expensive but improves co-morbidity: 5-year assessment of patients with obesity and type 2 diabetes. British Journal of Surgery, 108(5), pp. 554-565. (doi: 10.1002/bjs.11970) (PMID:32990329)

Lee, M. M.Y. et al. (2021) Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations. Open Heart, 8(1), e001453. (doi: 10.1136/openhrt-2020-001453) (PMID:33637568) (PMCID:PMC7919592)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Bauersachs, R., Wu, O. , Hawkins, N. , Bowrin, K., Wojciechowski, P., Clay, E. and Huelsebeck, M. (2021) Efficacy and safety of rivaroxaban compared with other therapies used in patients with peripheral artery disease undergoing peripheral revascularization: a systematic literature review and network meta-analysis. Cardiovascular Therapeutics, 2021, 8561350. (doi: 10.1155/2021/8561350) (PMID:34497668) (PMCID:PMC8407972)

Toi, P. L., Wu, O. , Thavorncharoensap, M., Srinonprasert, V., Anothaisintawee, T., Thakkinstian, A., Phuong, N. K. and Chaikledkaew, U. (2021) Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam. PLoS ONE, 16(12), e0261231. (doi: 10.1371/journal.pone.0261231) (PMID:34941883) (PMCID:PMC8700026)

Turongkaravee, S., Jittikoon, J., Rochanathimoke, O., Boyd, K. , Wu, O. and Chaikledkaew, U. (2021) Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation. BMC Health Services Research, 21, 1042. (doi: 10.1186/s12913-021-07025-8) (PMID:34600523) (PMCID:PMC8487501)

2020

McMeekin, P., Geue, C. , Mocevic, E., Hoxer, C.S., Ochs, A., McGurnaghan, S., Colhoun, H.M., Wild, S.H. and Wu, O. (2020) The cost of prevalent and incident cardiovascular disease in people with type 2 diabetes in Scotland: Data from the Scottish Care Information - Diabetes Collaboration (SCI-Diabetes). Diabetic Medicine, 37(11), pp. 1927-1934. (doi: 10.1111/dme.14253) (PMID:31989661)

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2020) Mechanical thrombectomy in patients with acute ischemic stroke: a cost-effectiveness and value of implementation analysis. International Journal of Stroke, 15(8), pp. 881-898. (doi: 10.1177/1747493019879656) (PMID:31564243)

Due, O. T., Thakkinstian, A., Thavorncharoensap, M., Sobhonslidsuk, A., Wu, O. , Phuong, N. K. and Chaikledkaew, U. (2020) Cost-utility analysis of direct-acting antivirals for treatment of chronic hepatitis C genotype 1 and 6 in Vietnam. Value in Health, 23(9), pp. 1180-1190. (doi: 10.1016/j.jval.2020.03.018) (PMID:32940236) (PMCID:PMC7491253)

Manyonda, I. et al. (2020) Uterine-artery embolization or myomectomy for uterine fibroids. New England Journal of Medicine, 383(5), pp. 440-451. (doi: 10.1056/NEJMoa1914735) (PMID:32726530)

Bauersachs, R., Wu, O. , Briere, J.-B., Bowrin, K., Borkowska, K., Jakubowska, A., Taieb, V., Toumi, M. and Huelsebeck, M. (2020) Antithrombotic treatments in patients with chronic coronary artery disease or peripheral artery disease: a systematic review of randomised controlled trials. Cardiovascular Therapeutics, 2020, 3057168. (doi: 10.1155/2020/3057168)

McMeekin, N., Wu, O. , Germeni, E. and Briggs, A. (2020) How methodological frameworks are being developed: evidence from a scoping review. BMC Medical Research Methodology, 20, 173. (doi: 10.1186/s12874-020-01061-4) (PMID:32605535) (PMCID:PMC7325096)

Baillie, K. et al. (2020) Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland. Pharmacoepidemiology and Drug Safety, 29(6), pp. 653-663. (doi: 10.1002/pds.4998) (PMID:32316077)

Cadilhac, D. A. et al. (2020) Improving economic evaluations in stroke: a report from the ESO Health Economics Working Group. European Stroke Journal, 5(2), pp. 184-192. (doi: 10.1177/2396987319897466) (PMID:32637652) (PMCID:PMC7313366)

Hsieh, P.-H., Wu, O. , Geue, C. , McIntosh, E. , McInnes, I. B. and Siebert, S. (2020) The economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Annals of the Rheumatic Diseases, 79(6), pp. 771-777. (doi: 10.1136/annrheumdis-2019-216243) (PMID:32245893)

Kanie, T., Mizuno, A., Yoneoka, D., Tam, W. W. S., Morze, J., Rynkiewicz, A., Xin, Y., Wu, O. and Kwong, J. S. (2020) Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews, 2020(6), CD013650. (doi: 10.1002/14651858.cd013650) (PMCID:PMC7387055)

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Ciminata, G., Geue, C. , Langhorne, P. and Wu, O. (2020) A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland. BMJ Open, 10(3), e028575. (doi: 10.1136/bmjopen-2018-028575) (PMID:32193256)

Sidik, N. P. et al. (2020) Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. American Heart Journal, 221, pp. 48-59. (doi: 10.1016/j.ahj.2019.11.015) (PMID:31911341) (PMCID:PMC7029345)

Wu, T., Wong, S. K. H., Law, B. T. T., Grieve, E. , Wu, O. , Tong, D. K. H., Leung, D. K. W., Lam, C. L. K. and Wong, C. K. H. (2020) Five‐year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population‐based propensity score‐matched cohort study. Diabetes/Metabolism Research and Reviews, 36(3), e3236. (doi: 10.1002/dmrr.3236) (PMID:31912598)

Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

2019

Lee, M. M.Y. et al. (2019) Invasive versus medical management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: a pilot randomized controlled trial. Circulation: Cardiovascular Interventions, 12(8), e007830. (doi: 10.1161/CIRCINTERVENTIONS.119.007830) (PMID:31362541)

Ryan, C., Hesselgreaves, H., Wu, O. , Moss, J. G., Paul, J. , Dixon-Hughes, J. and Germeni, E. (2019) Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study. BMJ Open, 9(7), e026077. (doi: 10.1136/bmjopen-2018-026077) (PMID:31292176) (PMCID:PMC6624052)

Gao, L., Sheppard, L., Wu, O. , Churilov, L., Mohebbi, M., Collier, J., Bernhardt, J., Ellery, F., Dewey, H. and Moodie, M. (2019) Economic evaluation of a phase III international randomised controlled trial of very early mobilisation after stroke (AVERT). BMJ Open, 9(5), e026230. (doi: 10.1136/bmjopen-2018-026230) (PMID:31118178) (PMCID:PMC6537993)

Paul, L., Renfrew, L., Freeman, J., Murray, H., Weller, B., Mattison, P., McConnachie, A. , Heggie, R., Wu, O. and Coulter, E. H. (2019) Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clinical Rehabilitation, 33(3), pp. 473-484. (doi: 10.1177/0269215518817080) (PMID:30514108)

Briere, J.-B., Bowrin, K., Coleman, C., Fauchier, L., Levy, P., Folkerts, K., Toumi, M., Taieb, V., Millier, A. and Wu, O. (2019) Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 19(19), pp. 27-36. (doi: 10.1080/14737167.2018.1518134) (PMID:30169975)

Coleman, C. I., Briere, J.-B., Fauchier, L., Levy, P., Bowrin, K., Toumi, M., Millier, A., Taieb, V. and Wu, O. (2019) Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation. Journal of Market Access and Health Policy, 7(1), 1574541. (doi: 10.1080/20016689.2019.1574541) (PMID:30774786) (PMCID:PMC6366429)

2018

Salgado Riveros, B., Torelli Reis, W. C., Lucchetta, R. C., Moreira, L. B., Lewsey, J. , Correr, C. J. and Wu, O. (2018) Brazilian analytical decision model for cardiovascular disease: an adaptation of the Scottish Cardiovascular Disease Policy Model. Value in Health Regional Issues, 17, pp. 210-216. (doi: 10.1016/j.vhri.2018.01.002) (PMID:30502691)

Mueller, T., Alvarez-Madrazo, S., Robertson, C., Wu, O. and Bennie, M. (2018) Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland. British Journal of Clinical Pharmacology, 85(2), pp. 422-431. (doi: 10.1111/bcp.13814) (PMID:30423191) (PMCID:PMC6339970)

Urimubenshi, G. , Cadilhac, D. A., Kagwiza, J. N., Wu, O. and Langhorne, P. (2018) Stroke care in Africa: a systematic review of the literature. International Journal of Stroke, 13(8), pp. 797-805. (doi: 10.1177/1747493018772747) (PMID:29664359)

Sangroongruangsri, S. et al. (2018) Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: a prospective observational study. Clinical Drug Investigation, 38(9), pp. 853-865. (doi: 10.1007/s40261-018-0678-5) (PMID:30069864) (PMCID:PMC6153972)

Ryan, C., Hesselgreaves, H., Wu, O. , Paul, J. , Dixon-Hughes, J. and Moss, J. G. (2018) Protocol for a systematic review and thematic synthesis of patient experiences of central venous access devices in anti-cancer treatment. Systematic Reviews, 7, 61. (doi: 10.1186/s13643-018-0721-x) (PMID:29669583) (PMCID:PMC5907379)

Wright, C. M., Boudarène, L., Ha, N. T., Wu, O. and Hawkins, N. (2018) A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18, 373. (doi: 10.1186/s12889-018-5261-8) (PMID:29558894) (PMCID:PMC5859762)

Lee, M. M.Y. et al. (2018) Non-Invasive Versus Invasive Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: Comparisons Between the Randomized Controlled Pilot Trial and Registry. ACC.18, Orlando, FL, USA, 10-12 Mar 2018. A45. (doi: 10.1016/S0735-1097(18)30586-2)

Wong, C. K. H., Wu, O. and Cheung, B. M.Y. (2018) Towards a transparent, credible, evidence-based decision-making process of new drug listing on the Hong Kong Hospital Authority Drug Formulary: challenges and suggestions. Applied Health Economics and Health Policy, 16(1), pp. 5-14. (doi: 10.1007/s40258-017-0339-5) (PMID:28702874)

Lee, M. M.Y. et al. (2018) Routine Non-invasive vs Invasive Management in Patients With Prior CABG With a NSTE-ACS: a Randomised Controlled Trial. British Cardiovascular Intervention Society Young Investigator Award Shortlisted Presentations, London, UK, 30 Nov 2017. A5.2-A6. (doi: 10.1136/heartjnl-2018-BCIS.9)

Sangroongruangsri, S., Ratanapakorn, T., Wu, O. , Anothaisintawee, T. and Chaikledkaew, U. (2018) Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis. Expert Review of Clinical Pharmacology, 11(9), pp. 903-916. (doi: 10.1080/17512433.2018.1507735) (PMID:30071180)

Zanghelini, F., Zimmermann, I. R., Souza de Andrade, C. A. and Wu, O. (2018) Early palliative care for improving quality of life and survival in patients with advanced cancer: a systematic review and meta-analysis. Journal of Palliative Care and Medicine, 8(5), 1000343. (doi: 10.4172/2165-7386.1000343)

2017

Grieve, E. , Hesselgreaves, H., Wu, O. , Chalkidou, K., Ruiz, F., Smith, P., Li, R., Morris, L. and Briggs, A. (2017) The Value of Health Technology Assessment: a mixed methods framework. F1000Research, 6, 2171. (doi: 10.7490/f1000research.1115169.1)

Urimubenshi, G. , Langhorne, P. , Cadilhac, D. A., Kagwiza, J. N. and Wu, O. (2017) Association between patient outcomes and key performance indicators of stroke care quality: A systematic review and meta-analysis. European Stroke Journal, 2(4), pp. 287-307. (doi: 10.1177/2396987317735426)

McMeekin, N., Briggs, A. and Wu, O. (2017) Developing A Conceptual Modelling Framework For Economic Evaluation. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A754-A755. (doi: 10.1016/j.jval.2017.08.2120)

Langhorne, P. , Wu, O. , Rodgers, H., Ashburn, A. and Bernhardt, J. (2017) A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial. Health Technology Assessment, 21(54), pp. 1-120. (doi: 10.3310/hta21540) (PMID:28967376)

Coulter, E.H. et al. (2017) Validity of the activPAL3 activity monitor in people moderately affected by Multiple Sclerosis. Medical Engineering and Physics, 45, pp. 78-82. (doi: 10.1016/j.medengphy.2017.03.008) (PMID:28408158)

Flowers, P. et al. (2017) The clinical effectiveness of individual behaviour change interventions to reduce risky sexual behaviour after a negative human immunodeficiency virus test in men who have sex with men: systematic and realist reviews and intervention development. Health Technology Assessment, 21(5), (doi: 10.3310/hta21050) (PMID:28145220)

de Souza Cazarim, M., Reis, R., Wu, O. , Lopes Rijo, R. P. C., Teixeira Vinci, A. L., Alves, D. and Leira Pereira, L. R. (2017) Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS). Procedia Computer Science, 121, pp. 376-383. (doi: 10.1016/j.procs.2017.11.051)

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. 3rd European Stroke Organisation Conference (ESOC), Prague, Czech Republic, 16-18 May 2017.

2016

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi: 10.1016/j.jval.2016.09.1685)

Xin, Y. , Mason, J., Govan, L. , Harbour, R., Bennison, J., Watson, E. and Wu, O. (2016) Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. BMC Gastroenterology, 16, 80. (doi: 10.1186/s12876-016-0491-7) (PMID:27460211) (PMCID:PMC4962503)

Luker, J. A., Craig, L. E., Bennett, L., Ellery, F., Langhorne, P. , Wu, O. and Bernhardt, J. (2016) Implementing a complex rehabilitation intervention in a stroke trial: a qualitative process evaluation of AVERT. BMC Medical Research Methodology, 16, 52. (doi: 10.1186/s12874-016-0156-9) (PMID:27164839) (PMCID:PMC4862225)

Geue, C. , Wu, O. , Leyland, A. , Lewsey, J. and Quinn, T. J. (2016) Geographic variation of inpatient care costs at the end of life. Age and Ageing, 45(3), pp. 376-381. (doi: 10.1093/ageing/afw040) (PMID:27025763) (PMCID:PMC4846794)

Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)

Lewis, S. C., Bhattacharya, S., Wu, O. , Vincent, K., Jack, S. A., Critchley, H. O.D., Porter, M. A., Cranley, D., Wilson, J. A. and Horne, A. W. (2016) Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A pilot randomised controlled trial. PLoS ONE, 11(4), e0153037. (doi: 10.1371/journal.pone.0153037) (PMID:27070434) (PMCID:PMC4829183)

Sheppard, L., Dewey, H., Bernhardt, J., Collier, J. M., Ellery, F., Churilov, L., Tay-Teo, K., Wu, O. and Moodie, M. (2016) Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care. International Journal of Stroke, 11(4), pp. 492-494. (doi: 10.1177/1747493016632254) (PMID:26936861)

2015

Geue, C. , Wu, O. , Xin, Y. , Heggie, R., Hutchinson, S., Martin, N. K., Fenwick, E. and Goldberg, D. (2015) Cost-effectiveness of HBV and HCV screening strategies – a systematic review of existing modelling techniques. PLoS ONE, 10(12), e0145022. (doi: 10.1371/journal.pone.0145022) (PMID:26689908) (PMCID:PMC4686364)

Wright, W., Turner, S., Anopa, Y., McIntosh, E. , Wu, O. , Conway, D. I. , Macpherson, L. M. D. and McMahon, A. D. (2015) Comparison of the caries-protective effect of fluoride varnish with treatment as usual in nursery school attendees receiving preventive oral health support through the Childsmile oral health improvement programme. The Protecting Teeth@3 Study: a randomised controlled trial. BMC Oral Health, 15(1), 160. (doi: 10.1186/s12903-015-0146-z) (PMID:26681191) (PMCID:PMC4683783)

Govan, L. , Wu, O. , Xin, Y. , Hutchinson, S. J. and Hawkins, N. (2015) Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis. European Journal of Gastroenterology and Hepatology, 27(8), pp. 882-894. (doi: 10.1097/meg.0000000000000376) (PMID:25919772)

Ponomarev, D., Miller, C. , Govan, L. , Haig, C. , Wu, O. and Langhorne, P. (2015) Complications following incident stroke resulting in readmissions: an analysis of data from three Scottish health surveys. International Journal of Stroke, 10(6), pp. 911-917. (doi: 10.1111/ijs.12191) (PMID:24206656)

Govan, L. , Wu, O. , Lindsay, R. and Briggs, A. (2015) How do diabetes models measure up? A review of diabetes economic models and ADA guidelines. Journal of Health Economics and Outcomes Research, 3(2), pp. 132-152.

2014

McPherson, K., Manyonda, I., Lumsden, M.-A. , Belli, A.-M., Moss, J., Wu, O. , Middleton, L. and Daniels, J. (2014) A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial. Trials, 15(1), p. 468. (doi: 10.1186/1745-6215-15-468)

Craig, L. E., Wu, O. , Bernhardt, J. and Langhorne, P. (2014) Approaches to economic evaluations of stroke rehabilitation. International Journal of Stroke, 9(1), pp. 88-100. (doi: 10.1111/ijs.12041) (PMID:23521855)

Iliodromiti, S., Kelsey, T. W., Wu, O. , Anderson, R. A. and Nelson, S. M. (2014) The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Human Reproduction Update, 20(4), pp. 560-570. (doi: 10.1093/humupd/dmu003) (PMID:24532220)

Kulkarni, S., Wu, O. , Kasthuri, R. and Moss, J.G. (2014) Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications. CardioVascular and Interventional Radiology, 37(4), pp. 990-1008. (doi: 10.1007/s00270-013-0771-3)

2013

Palmateer, N.E., Hutchinson, S.A., Innes, H., Schnier, C., Wu, O. , Goldberg, D.J. and Hickman, M. (2013) Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. International Journal of Drug Policy, 24(2), pp. 85-100. (doi: 10.1016/j.drugpo.2012.08.006)

2012

Wu, O. , Briggs, A. and MacIntyre, K. (2012) Mobile phone use for contacting emergency services in life-threatening circumstances. Journal of Emergency Medicine, 42(3), pp. 291-298. (doi: 10.1016/j.jemermed.2011.02.022)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55(9), pp. 2356-2360. (doi: 10.1007/s00125-012-2601-6)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O. , Jack, S., Porter, M., Lewis, S. and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi: 10.1136/bmjopen-2012-001297)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O. , Jack, S., Porter, M., Lewis, S. and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin of the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi: 10.1136/bmjopen-2012-001297)

Westaby, D.T., Wu, O. , Duncan, W., Critchley, H.O.D., Tong, S. and Horne, A.W. (2012) Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery? BMC Pregnancy and Childbirth, 12(98), (doi: 10.1186/1471-2393-12-98)

2011

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(9), pp. 1992-1997. (doi: 10.2337/dc10-2099)

Craig, L.E., Wu, O. , Bernhardt, J. and Langhorne, P. (2011) Predictors of poststroke mobility: systematic review. International Journal of Stroke, 6(4), pp. 321-327. (doi: 10.1111/j.1747-4949.2011.00621.x)

Clarke, P. and Wu, O. (2011) ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiology, 7(2), pp. 191-201. (doi: 10.2217/fca.10.191)

Craig, L.E., Wu, O. , Gilmour, H., Barber, M. and Langhorne, P. (2011) Developing and validating a predictive model for stroke progression. Cerebrovascular Diseases, 1(1), pp. 105-114. (doi: 10.1159/000334473)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi: 10.1007/s00125-011-2176-7)

Moss, J.G., Cooper, K.G., Khaund, A., Murray, L., Murray, G.D., Wu, O. , Craig, L.E. and Lumsden, M.A. (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: An International Journal of Obstetrics and Gynaecology, 118(8), pp. 936-944. (doi: 10.1111/j.1471-0528.2011.02952.x)

Wellwood, I., Wu, O. , Langhorne, P. , McKevitt, C., Di Carlo, A., Rudd, A.G. and Wolfe, C.D.A. (2011) Developing a tool to assess quality of stroke care across European populations: The EROS quality assessment tool. Stroke, 42(5), pp. 1207-1211. (doi: 10.1161/STROKEAHA.110.598938)

2010

Adachi, J. D. et al. (2010) Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women. Mayo Clinic Proceedings, 85(9), pp. 806-813. (doi: 10.4065/mcp.2010.0082)

Alcorn, N., Tierney, A., Wu, O. , Gilmour, H. and Madhok, R. (2010) Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(8), p. 1571. (doi: 10.1136/ard.2009.122424)

Clark, P., Wu, O. , Greer, I.A. and Lowe, G.D.O. (2010) Venous thrombosis prevention more than just guidelines. British Journal of Haematology, 149(1), pp. 50-54. (doi: 10.1111/j.1365-2141.2010.08080.x)

Craig, L., Bernhardt, J., Langhorne, P. and Wu, O. (2010) Early mobilization after stroke: an example of an individual patient data meta-analysis of a complex intervention. Stroke, 41(11), pp. 2632-2636. (doi: 10.1161/STROKEAHA.110.588244)

2009

Wu, O., Levy, A.R., Briggs, A., Lewis, G. and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87(9), pp. 1330-1339. (doi: 10.1097/TP.0b013e3181a236e0)

Briggs, A. , Starkie, H. and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier: London, pp. 751-760. ISBN 9780123740014

Craig, L.E., Langhorne, P. , Wu, O. , Walters, M.R., Ritchie, C.K. and Smith, L.N. (2009) AVERT Scotland: introducing a very early rehabilitation trial (AVERT) to Scotland [POSTER]. Cerebrovascular Diseases, 27(suppl.), p. 241. (doi: 10.1159/000221782)

Kerr, G., Ray, G., Stott, D., Wu, O. and Langhorne, P. (2009) Elevated Troponin after Stroke: A Systematic Review. Cerebrovascular Diseases, 28(3), pp. 220-226. (doi: 10.1159/000226773)

Wu, O. (2009) Oral contraceptives and venous thromboembolism: identifying the safest option. Expert Reviews, 7(12), pp. 1513-1516. (doi: 10.1586/erc.09.151)

2008

Hirst, A., Dutton, S., Wu, O. , Briggs, A. , Edwards, C. , Waldenmaier, L., Maresh, M., Nicholson, A. and McPherson, K. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids: the HOPEFUL study. Health Technology Assessment, 12(5),

Clark, P., Walker, I.D., Govan, L. , Wu, O. and Greer, I.A. (2008) The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. British Journal of Haematology, 140(2), pp. 236-240. (doi: 10.1111/j.1365-2141.2007.06902.x)

Wu, O. , Bayoumi, N., Vickers, M. and Clark, P. (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 6(1), pp. 62-69. (doi: 10.1111/j.1538-7836.2007.02818.x)

Clark, P. and Wu, O. (2008) ABO(H) blood groups and pre-eclampsia - A systematic review and meta-analysis. Thrombosis and Haemostasis, 100(3), pp. 469-474.

Hirst, A., Dutton, S., Wu, O. , Briggs, A. , Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A. and McPherson, K. (2008) The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids. Health Technology Assessment, 123(5), pp. 1-248.

2007

Wu, O. , Briggs, A.H., Dutton, S., Hirst, A., Maresh, M., Nicholson, A. and McPherson, K. (2007) Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. BJOG: An International Journal of Obstetrics and Gynaecology, 114(11), pp. 1352-1362. (doi: 10.1111/j.1471-0528.2007.01525.x)

Wu, O. and Greer, I.A. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14(5), pp. 500-503. (doi: 10.1097/MOH.0b013e32825f5318)

Edwards, R.D., Moss, J.G., Lumsden, M.A. , Wu, O. , Murray, L.S., Twaddle, S. and Murray, G.D. (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine, 356(4), pp. 360-370.

Madhok, R. and Wu, O. (2007) Systemic lupus erythematosus. American Family Physician, 76(9), pp. 1351-1353.

Wu, O. and Greer, I. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14, pp. 500-503.

2006

Madhok, R., Wu, O. , McKellar, G. and Singh, G. (2006) Non-steroidal anti-inflammatory drugs—changes in prescribing may be warranted. Rheumatology, 45(12), pp. 1458-1460. (doi: 10.1093/rheumatology/kel353)

Wu, O. and Langhorne, P. (2006) The challenge of acute-stroke management: does telemedicine offer a solution? International Journal of Stroke, 1(4), pp. 201-207. (doi: 10.1111/j.1747-4949.2006.00062.x)

Wu, O. and Greer, I.A. (2006) More on 'universal' versus 'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis - response to Favaloro and Keeling. British Journal of Haematology, 134(2), p. 241. (doi: 10.1111/j.1365-2141.2006.06139.x)

Robertson, L. et al. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132(2), pp. 171-196. (doi: 10.1111/j.1365-2141.2005.05847.x)

Singh, G., Wu, O. , Langhorne, P. and Madhok, R. (2006) Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Research and Therapy, 8, R153. (doi: 10.1186/ar2047)

Wu, O. et al. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1-+.

Zatarain, E., Wu, O. and Singh, G. (2006) Non-steroidal anti-inflammatory drugs-COX-2 inhibition. In: Capell, H., Luthra, H.S. and Madhok, R. (eds.) The year in rheumatic disorders. Clinical Publishing: Oxford. ISBN 9786610309962

2005

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, pp. 17-25.

Wu, O. et al. (2005) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. British Journal of Haematology, 131, pp. 80-90. (doi: 10.1111/j.1365-2141.2005.05715.x)

Wu, O. (2005) Postmenopausal hormone replacement therapy and venous thromboembolism. Gender Medicine, 2(Supple), S18-S27. (doi: 10.1016/S1550-8579(05)80061-0)

Wu, O. , Clark, P., Lowe, G.D.O., Walker, I.D. and Greer, I.A. (2005) Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. Journal of Thrombosis and Haemostasis, 3(4), pp. 811-813. (doi: 10.1111/j.1538-7836.2005.01264.x)

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombosis and Haemostasis, 94(1), pp. 17-25. (doi: 10.1160/TH04-11-0759)

2004

Robertson, L., Wu, O. and Greer, I. (2004) Thrombophilia and adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology, 16(6), pp. 453-458.

Norman, J., Wu, O. , Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardyce, G. and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi: 10.1111/j.1471-0528.2004.00324.x)

Wu, O., Knill-Jones, R., Wilson, P. and Craig, N. (2004) The impact of economic information on medical decision making in primary care. Journal of Evaluation in Clinical Practice, 10(3), pp. 407-411. (doi: 10.1111/j.1365-2753.2004.00490.x)

Norman, J., Wu, O., Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardice, G. and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi: 10.1111/j.1471-0528.2004.00324.x)

This list was generated on Sun Nov 27 18:37:47 2022 GMT.

Jump to: Articles | Book Sections | Research Reports or Papers | Conference or Workshop Item

Number of items: 132.

Articles

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Manyonda, I. et al. (2020) Uterine-artery embolization or myomectomy for uterine fibroids. New England Journal of Medicine, 383(5), pp. 440-451. (doi: 10.1056/NEJMoa1914735) (PMID:32726530)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O. , Jack, S., Porter, M., Lewis, S. and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin of the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi: 10.1136/bmjopen-2012-001297)

Clarke, P. and Wu, O. (2011) ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiology, 7(2), pp. 191-201. (doi: 10.2217/fca.10.191)

Kerr, G., Ray, G., Stott, D., Wu, O. and Langhorne, P. (2009) Elevated Troponin after Stroke: A Systematic Review. Cerebrovascular Diseases, 28(3), pp. 220-226. (doi: 10.1159/000226773)

Wu, O. (2009) Oral contraceptives and venous thromboembolism: identifying the safest option. Expert Reviews, 7(12), pp. 1513-1516. (doi: 10.1586/erc.09.151)

Clark, P. and Wu, O. (2008) ABO(H) blood groups and pre-eclampsia - A systematic review and meta-analysis. Thrombosis and Haemostasis, 100(3), pp. 469-474.

Wu, O. and Greer, I.A. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14(5), pp. 500-503. (doi: 10.1097/MOH.0b013e32825f5318)

Madhok, R. and Wu, O. (2007) Systemic lupus erythematosus. American Family Physician, 76(9), pp. 1351-1353.

Wu, O. and Greer, I. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14, pp. 500-503.

Robertson, L. et al. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132(2), pp. 171-196. (doi: 10.1111/j.1365-2141.2005.05847.x)

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, pp. 17-25.

Wu, O. (2005) Postmenopausal hormone replacement therapy and venous thromboembolism. Gender Medicine, 2(Supple), S18-S27. (doi: 10.1016/S1550-8579(05)80061-0)

Robertson, L., Wu, O. and Greer, I. (2004) Thrombophilia and adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology, 16(6), pp. 453-458.

Book Sections

Research Reports or Papers

Conference or Workshop Item

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. 3rd European Stroke Organisation Conference (ESOC), Prague, Czech Republic, 16-18 May 2017.

This list was generated on Sun Nov 27 18:37:47 2022 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

Optimal implementation of Wolbachia wAlbB programmes for dengue control
Wellcome Trust
2022 - 2027
EVIS Trial
National Institute for Health Research
2021 - 2025
BEhavioural weight management: COMponents for Effectiveness
National Institute for Health Research
2020 - 2023
Living Lab: Driving Economic Growth in Glasgow through Real-World Implementation of Precision Medicine
UK Research and Innovation
2020 - 2025
The clinical utility of cardiac magnetic resonance imaging in patients with angina but no obstructive coronary disease: an observational study and nested clinical
British Heart Foundation
2020 - 2023
Understanding the mechanisms and effectiveness of lifestyle modification interventions in adults with learning disabilities.
National Institute for Health Research
2020 - 2022
Saeboglove therapy for severe Upper limb disability and Severe Hand Impairment after stroke
Chief Scientist Office
2019 - 2023
A randomised, double-blind placebo controlled trial of the effectiveness of the beta-blocker bisoprolol in preventing exacerbations of chronic obstructive pulmonary disease (BICS)
National Institute for Health Research
2018 - 2023
Incidence and the Economic burden of cardiovascular events in type 2 diabetes mellitus
Novo Nordisk
2017 - 2018
SFC-GCRF: A framework for the diagnosis and control of viral diseases in West Africa; from surveillance to health economics
Scottish Funding Council
2016 - 2017
Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) trial: A randomised controlled trial of mechanical thrombectomy in acute ischaemic stroke - Health Economics
National Institute for Health Research
2016 - 2016
SRP Complex Reviews Research Support Unit
National Institute for Health Research
2015 - 2020
Evidence Working Group
Bill and Melinda Gates Foundation
2015 - 2015
Web-based Physiotherapy for people with Multiple Sclerosis (WEB-PaMS)
Multiple Sclerosis Society
2015 - 2016
Individual interventions after testing for HIV to reduce risky sexual behaviour in men who have sex with men (MSM): A mixed method systematic review
National Institute for Health Research
2014 - 2015
Setting Scottish Stroke Services in an International Context
Chest Heart and Stroke Scotland
2014 - 2015
The effect of geography and socioeconomic status on health care costs at the end of life: implications for resource allocation and expenditure projections in Scotland
Chief Scientist Office
2014 - 2016
A very early rehabilitation trial after stroke (AVERT): A phase 3, multicentre, randomised controlled trial
National Institute for Health Research
2013 - 2016
Health Economics Assessment of GOLD acute Stroke Technology
Chief Scientist Office
2013 - 2013
Cancer and Venous Access (CAVA) - a three way randomised controlled trial of long-term venous access devices for the delivery of chemotherapy.
National Institute for Health Research
2013 - 2018
The Scottish eHealth Informatics Research Centre (E-HIRCs).
Medical Research Council
2013 - 2018
Costs and complications of diabetes - investigation in a comprehensive national diabetes register
Medical Research Council
2012 - 2015
Randomised controlled trial on the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women
Chief Scientist Office
2012 - 2014
A prospective randomised trial of myomectomy versus uterine artery embolisation (UAE) for women with uterine fibroids who wish to retain or improve their fertility (FEMME)
National Institute for Health Research
2011 - 2018
Port-a-cath and Hickman line devices for chemotherapy delivery: a feasibility study to measure clinical outcomes and health economic data prior to a randomised controlled trial.
Chief Scientist Office
2011 - 2013
A Very Early Rehabilitation Trial (AVERT) UK
Stroke Association
2010 - 2013
Implementation of complex interventions in stroke
Stroke Association
2009 - 2012
A multi-centre randomised controlled trial of very early mobilisation after stroke (AVERT) in Scotland
Scottish Government
2009 - 2010
A multi-centre randomised controlled trial of very early mobilisation after stroke (AVERT) in Scotland
Chest Heart and Stroke Scotland
2008 - 2010
Stock-take of guidance and audit relating to venous thrombosis prevention & treatment in NHS Scotland
NHS Quality Improvement Scotland
2008 - 2009
Long term (3-5 years) follow up and MRI imaging of the REST cohort trial
Scottish Executive Health Department
2007 - 2009

Supervision

Heggie, Robert
Implementation alongside cost-effectiveness analysis
Kamaruzaman, Hanin Farhana Binti
Disinvestment of health interventions and practices through health technology assessment: towards sustainable health care through effective resource allocation

Professional activities & recognition

Grant committees & research advisory boards

2020: NIHR, HTA Clinical Evaluation & Trials
2016 - 2019: NIHR, HTA General Funding
2015: NIHR, Evidence Synthesis Programme Advisory Group

Editorial boards

2019: Value in Health
2016: Global & Regional Health Technology Assessment

Research datasets

Jump to: 2022 | 2021

Number of items: 2.

2022

ROSS, K. , Keith, N. , Abbott, L., Adams, C., Aitken, E., Aslett, O., Basra, S., Bell, I., Bradley, J., Brown, T., Brown, W., Chen, R., Cheskin, L., Corrie, R., de Vries, E., Defty, E., Drake, H., Dunlop, H., Emadi, A. , Evans, J. , Everett, S., Feng, Z., Fraser, A., Gallacher, K. , Gaynor-Kirk, E., Halsey, C. , Harris, F., Hu, J., Hush, G., Jamieson, N. , Jameison, V., Jones, R. , Just, L., Lembo, T. , Lloyd, B., Ma, C.-L., Macdonald, S. , Mathias, M. , McAra, M., McCaffrey, B., Mccluskey, L.-A., Mchattie, L.-S., Mcneill, E., Milliken, A., Mogford, D., Morris, G., Nicoll, M., O'Brien, T., Onwuka, T., Papanastasatou, M., Perry, M. , Prosser, Z., Proudfoot, B., Raman Komnedath, S., Robinson, J. , Sleight, R., Smith, P., Stricevic, M., Tharp, B., Thoresson, V., Thorne, J., Vansteenhouse, H., Welisch, G. and Wu, O. (2022) Symbiotic Futures: Health, Well-being and Care in the Post-Covid World. [Data Collection]

2021

Ross, K., Keith, N. , Jones, R. , Hanna, C. , Afzal, I., Basra, S., Bell, I., Bennie, M., Berger, A., Bilsland, A., Blyth, K. , Borris, A., Boruc, M., Bradley, J., Caryl, J., Cerniauskaite, U., Cheskin, L., Chiwanda, J., Cooper, J. , Debiasse, K., Fegan, S., Ferguson, C., Halsey, C. , Harris, F., Herceg, Z., Hogg, C., Hush, G., Julien, A., Kameda, R., Keith, A., Kelly, J., Konieczna, Z., Lu, M. Y., Mackay, S., Marinescu-Duca, M., Maxwell, M., McCaffrey, R., McGuire, N., McIntyre, D., Moffat-Kyle, T., Mukherjee, L., O'Friel, A., Perry, M. , Prentice, J., Prosser, Z., Proudfoot, B., Raman, S., Robinson, J. , Smith, A., Stewart, S., Stricevic, M., Teal, G., Thomson, H., Wang, Z., Welisch, G., Wu, O. , Wu, H., Young, E. and Young, S. (2021) The Future of Cancer and Collective Intelligence in the Post-Covid World. [Data Collection]

This list was generated on Sun Nov 27 18:37:52 2022 GMT.

Portrait of Olivia Wu

We use cookies

Necessary cookies

Analytics cookies

Hotjar

Marketing cookies

Professor Olivia Wu

Biography

Research interests

Publications

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Articles

Book Sections

Research Reports or Papers

Conference or Workshop Item

Grants

Supervision

Professional activities & recognition

Grant committees & research advisory boards

Editorial boards

Research datasets

2022

2021